Q32 Bio
QTTB
106 hedge funds and large institutions have $366M invested in Q32 Bio in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 27 increasing their positions, 38 reducing their positions, and 19 closing their positions.
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
4% more funds holding
Funds holding: 102 → 106 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.44% less ownership
Funds ownership: 4.64% → 4.2% (-0.44%)
3% less call options, than puts
Call options by funds: $1.98M | Put options by funds: $2.04M
29% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 38
36% less capital invested
Capital invested by funds: $574M → $366M (-$208M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.6M |
| 2 |
JP Morgan Chase
New York
|
+$2.23M |
| 3 |
Goldman Sachs
New York
|
+$1.51M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.47M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$22.8M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$10M |
| 3 |
State Street
Boston,
Massachusetts
|
-$9.44M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.8M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.34M |
QTTB Hedge Fund Activity: Q3 2020 in Review
106 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2020, worth a combined $366M — down 36% from $574M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new QTTB positions and 19 closed out — a net gain of 6 holders — while 27 added to existing stakes and 38 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $13.6M. The largest seller was RTW Investments, cutting an estimated $22.8M.
- 106 institutional investors held Q32 Bio (QTTB) as of Q3 2020, up from 102 in Q2 2020.
- Funds reported $366M of Q32 Bio stock for Q3 2020, down 36% quarter-over-quarter.
- 25 funds opened new Q32 Bio positions in Q3 2020 and 19 closed out, a net change of +6 holders.
- The largest Q32 Bio buyer in Q3 2020 was Wellington Management Group, an estimated $13.6M added.
- The largest Q32 Bio seller in Q3 2020 was RTW Investments, an estimated $22.8M sold.
Based on aggregated 13F filings for Q3 2020.